img

Global Amlodipine Besylate Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Amlodipine Besylate Market Insights, Forecast to 2034

Amlodipine Besylate is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment ofHypertension and Coronary Artery Disease.
Global Amlodipine Besylate market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Amlodipine Besylate industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Amlodipine Besylate key manufacturers include Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma and Upsher-Smith Laboratories, etc. Pfizer, Mylan, Dr. Reddy's Laboratories are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Amlodipine Besylate were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Amlodipine Besylate market and estimated to attract more attentions from industry insiders and investors.
Amlodipine Besylate can be divided into 2.5mg Tablets, 5mg Tablets and 10mg Tablets,, etc. 2.5mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Amlodipine Besylate is widely used in various fields, such as High Blood Pressure and Heart Disease, etc. High Blood Pressure provides greatest supports to the Amlodipine Besylate industry development. In 2022, global % sales of Amlodipine Besylate went into High Blood Pressure filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Amlodipine Besylate market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Amlodipine Besylate market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Teva Pharmaceutical
Cipla
Hikma Pharmaceuticals
Strides Pharma
Upsher-Smith Laboratories
InvaGen Pharmaceuticals
Sun Pharmaceutical
Aurobindo Pharma
Lupin Pharmaceuticals
Zydus Pharmaceuticals
Oxford Pharm
Wockhardt
Epic Pharma
CR Pharmaceutical
Alkem Laboratories
MACLEODS
Segment by Type
2.5mg Tablets
5mg Tablets
10mg Tablets

Segment by Application


High Blood Pressure
Heart Disease

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Amlodipine Besylate plant distribution, commercial date of Amlodipine Besylate, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Amlodipine Besylate introduction, etc. Amlodipine Besylate Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Amlodipine Besylate
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Amlodipine Besylate Product Introduction
1.2 Market by Type
1.2.1 Global Amlodipine Besylate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 2.5mg Tablets
1.2.3 5mg Tablets
1.2.4 10mg Tablets
1.3 Market by Application
1.3.1 Global Amlodipine Besylate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 High Blood Pressure
1.3.3 Heart Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Amlodipine Besylate Sales Estimates and Forecasts 2018-2029
2.2 Global Amlodipine Besylate Revenue by Region
2.2.1 Global Amlodipine Besylate Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Amlodipine Besylate Revenue by Region (2018-2024)
2.2.3 Global Amlodipine Besylate Revenue by Region (2024-2029)
2.2.4 Global Amlodipine Besylate Revenue Market Share by Region (2018-2029)
2.3 Global Amlodipine Besylate Sales Estimates and Forecasts 2018-2029
2.4 Global Amlodipine Besylate Sales by Region
2.4.1 Global Amlodipine Besylate Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Amlodipine Besylate Sales by Region (2018-2024)
2.4.3 Global Amlodipine Besylate Sales by Region (2024-2029)
2.4.4 Global Amlodipine Besylate Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Amlodipine Besylate Sales by Manufacturers
3.1.1 Global Amlodipine Besylate Sales by Manufacturers (2018-2024)
3.1.2 Global Amlodipine Besylate Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Amlodipine Besylate in 2022
3.2 Global Amlodipine Besylate Revenue by Manufacturers
3.2.1 Global Amlodipine Besylate Revenue by Manufacturers (2018-2024)
3.2.2 Global Amlodipine Besylate Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Amlodipine Besylate Revenue in 2022
3.3 Global Key Players of Amlodipine Besylate, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Amlodipine Besylate Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Amlodipine Besylate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Amlodipine Besylate, Product Offered and Application
3.8 Global Key Manufacturers of Amlodipine Besylate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Amlodipine Besylate Sales by Type
4.1.1 Global Amlodipine Besylate Historical Sales by Type (2018-2024)
4.1.2 Global Amlodipine Besylate Forecasted Sales by Type (2024-2029)
4.1.3 Global Amlodipine Besylate Sales Market Share by Type (2018-2029)
4.2 Global Amlodipine Besylate Revenue by Type
4.2.1 Global Amlodipine Besylate Historical Revenue by Type (2018-2024)
4.2.2 Global Amlodipine Besylate Forecasted Revenue by Type (2024-2029)
4.2.3 Global Amlodipine Besylate Revenue Market Share by Type (2018-2029)
4.3 Global Amlodipine Besylate Price by Type
4.3.1 Global Amlodipine Besylate Price by Type (2018-2024)
4.3.2 Global Amlodipine Besylate Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Amlodipine Besylate Sales by Application
5.1.1 Global Amlodipine Besylate Historical Sales by Application (2018-2024)
5.1.2 Global Amlodipine Besylate Forecasted Sales by Application (2024-2029)
5.1.3 Global Amlodipine Besylate Sales Market Share by Application (2018-2029)
5.2 Global Amlodipine Besylate Revenue by Application
5.2.1 Global Amlodipine Besylate Historical Revenue by Application (2018-2024)
5.2.2 Global Amlodipine Besylate Forecasted Revenue by Application (2024-2029)
5.2.3 Global Amlodipine Besylate Revenue Market Share by Application (2018-2029)
5.3 Global Amlodipine Besylate Price by Application
5.3.1 Global Amlodipine Besylate Price by Application (2018-2024)
5.3.2 Global Amlodipine Besylate Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Amlodipine Besylate Market Size by Type
6.1.1 US & Canada Amlodipine Besylate Sales by Type (2018-2029)
6.1.2 US & Canada Amlodipine Besylate Revenue by Type (2018-2029)
6.2 US & Canada Amlodipine Besylate Market Size by Application
6.2.1 US & Canada Amlodipine Besylate Sales by Application (2018-2029)
6.2.2 US & Canada Amlodipine Besylate Revenue by Application (2018-2029)
6.3 US & Canada Amlodipine Besylate Market Size by Country
6.3.1 US & Canada Amlodipine Besylate Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Amlodipine Besylate Sales by Country (2018-2029)
6.3.3 US & Canada Amlodipine Besylate Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Amlodipine Besylate Market Size by Type
7.1.1 Europe Amlodipine Besylate Sales by Type (2018-2029)
7.1.2 Europe Amlodipine Besylate Revenue by Type (2018-2029)
7.2 Europe Amlodipine Besylate Market Size by Application
7.2.1 Europe Amlodipine Besylate Sales by Application (2018-2029)
7.2.2 Europe Amlodipine Besylate Revenue by Application (2018-2029)
7.3 Europe Amlodipine Besylate Market Size by Country
7.3.1 Europe Amlodipine Besylate Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Amlodipine Besylate Sales by Country (2018-2029)
7.3.3 Europe Amlodipine Besylate Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Amlodipine Besylate Market Size
8.1.1 China Amlodipine Besylate Sales (2018-2029)
8.1.2 China Amlodipine Besylate Revenue (2018-2029)
8.2 China Amlodipine Besylate Market Size by Application
8.2.1 China Amlodipine Besylate Sales by Application (2018-2029)
8.2.2 China Amlodipine Besylate Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Amlodipine Besylate Market Size by Type
9.1.1 Asia Amlodipine Besylate Sales by Type (2018-2029)
9.1.2 Asia Amlodipine Besylate Revenue by Type (2018-2029)
9.2 Asia Amlodipine Besylate Market Size by Application
9.2.1 Asia Amlodipine Besylate Sales by Application (2018-2029)
9.2.2 Asia Amlodipine Besylate Revenue by Application (2018-2029)
9.3 Asia Amlodipine Besylate Sales by Region
9.3.1 Asia Amlodipine Besylate Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Amlodipine Besylate Revenue by Region (2018-2029)
9.3.3 Asia Amlodipine Besylate Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Amlodipine Besylate Market Size by Type
10.1.1 Middle East, Africa and Latin America Amlodipine Besylate Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Amlodipine Besylate Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Amlodipine Besylate Market Size by Application
10.2.1 Middle East, Africa and Latin America Amlodipine Besylate Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Amlodipine Besylate Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Amlodipine Besylate Sales by Country
10.3.1 Middle East, Africa and Latin America Amlodipine Besylate Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Amlodipine Besylate Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Amlodipine Besylate Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Overview
11.2.3 Mylan Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Mylan Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Information
11.3.2 Dr. Reddy's Laboratories Overview
11.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dr. Reddy's Laboratories Recent Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Overview
11.4.3 Apotex Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Apotex Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Recent Developments
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Information
11.5.2 Teva Pharmaceutical Overview
11.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Teva Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Pharmaceutical Recent Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Overview
11.6.3 Cipla Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Cipla Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Recent Developments
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Information
11.7.2 Hikma Pharmaceuticals Overview
11.7.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Hikma Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hikma Pharmaceuticals Recent Developments
11.8 Strides Pharma
11.8.1 Strides Pharma Company Information
11.8.2 Strides Pharma Overview
11.8.3 Strides Pharma Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Strides Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Strides Pharma Recent Developments
11.9 Upsher-Smith Laboratories
11.9.1 Upsher-Smith Laboratories Company Information
11.9.2 Upsher-Smith Laboratories Overview
11.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Upsher-Smith Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Upsher-Smith Laboratories Recent Developments
11.10 InvaGen Pharmaceuticals
11.10.1 InvaGen Pharmaceuticals Company Information
11.10.2 InvaGen Pharmaceuticals Overview
11.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 InvaGen Pharmaceuticals Recent Developments
11.11 Sun Pharmaceutical
11.11.1 Sun Pharmaceutical Company Information
11.11.2 Sun Pharmaceutical Overview
11.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Sun Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sun Pharmaceutical Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Information
11.12.2 Aurobindo Pharma Overview
11.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Aurobindo Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aurobindo Pharma Recent Developments
11.13 Lupin Pharmaceuticals
11.13.1 Lupin Pharmaceuticals Company Information
11.13.2 Lupin Pharmaceuticals Overview
11.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Lupin Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Lupin Pharmaceuticals Recent Developments
11.14 Zydus Pharmaceuticals
11.14.1 Zydus Pharmaceuticals Company Information
11.14.2 Zydus Pharmaceuticals Overview
11.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Zydus Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Zydus Pharmaceuticals Recent Developments
11.15 Oxford Pharm
11.15.1 Oxford Pharm Company Information
11.15.2 Oxford Pharm Overview
11.15.3 Oxford Pharm Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Oxford Pharm Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Oxford Pharm Recent Developments
11.16 Wockhardt
11.16.1 Wockhardt Company Information
11.16.2 Wockhardt Overview
11.16.3 Wockhardt Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Wockhardt Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Wockhardt Recent Developments
11.17 Epic Pharma
11.17.1 Epic Pharma Company Information
11.17.2 Epic Pharma Overview
11.17.3 Epic Pharma Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Epic Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Epic Pharma Recent Developments
11.18 CR Pharmaceutical
11.18.1 CR Pharmaceutical Company Information
11.18.2 CR Pharmaceutical Overview
11.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 CR Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 CR Pharmaceutical Recent Developments
11.19 Alkem Laboratories
11.19.1 Alkem Laboratories Company Information
11.19.2 Alkem Laboratories Overview
11.19.3 Alkem Laboratories Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Alkem Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Alkem Laboratories Recent Developments
11.20 MACLEODS
11.20.1 MACLEODS Company Information
11.20.2 MACLEODS Overview
11.20.3 MACLEODS Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 MACLEODS Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 MACLEODS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Amlodipine Besylate Industry Chain Analysis
12.2 Amlodipine Besylate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Amlodipine Besylate Production Mode & Process
12.4 Amlodipine Besylate Sales and Marketing
12.4.1 Amlodipine Besylate Sales Channels
12.4.2 Amlodipine Besylate Distributors
12.5 Amlodipine Besylate Customers
13 Market Dynamics
13.1 Amlodipine Besylate Industry Trends
13.2 Amlodipine Besylate Market Drivers
13.3 Amlodipine Besylate Market Challenges
13.4 Amlodipine Besylate Market Restraints
14 Key Findings in The Global Amlodipine Besylate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Amlodipine Besylate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 2.5mg Tablets
Table 3. Major Manufacturers of 5mg Tablets
Table 4. Major Manufacturers of 10mg Tablets
Table 5. Global Amlodipine Besylate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Amlodipine Besylate Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Amlodipine Besylate Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Amlodipine Besylate Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Amlodipine Besylate Revenue Market Share by Region (2018-2024)
Table 10. Global Amlodipine Besylate Revenue Market Share by Region (2024-2029)
Table 11. Global Amlodipine Besylate Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Amlodipine Besylate Sales by Region (2018-2024) & (K Units)
Table 13. Global Amlodipine Besylate Sales by Region (2024-2029) & (K Units)
Table 14. Global Amlodipine Besylate Sales Market Share by Region (2018-2024)
Table 15. Global Amlodipine Besylate Sales Market Share by Region (2024-2029)
Table 16. Global Amlodipine Besylate Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Amlodipine Besylate Sales Share by Manufacturers (2018-2024)
Table 18. Global Amlodipine Besylate Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Amlodipine Besylate Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Amlodipine Besylate, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Amlodipine Besylate Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Amlodipine Besylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Amlodipine Besylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2022)
Table 24. Global Key Manufacturers of Amlodipine Besylate, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Amlodipine Besylate, Product Offered and Application
Table 26. Global Key Manufacturers of Amlodipine Besylate, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Amlodipine Besylate Sales by Type (2018-2024) & (K Units)
Table 29. Global Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 30. Global Amlodipine Besylate Sales Share by Type (2018-2024)
Table 31. Global Amlodipine Besylate Sales Share by Type (2024-2029)
Table 32. Global Amlodipine Besylate Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Amlodipine Besylate Revenue Share by Type (2018-2024)
Table 35. Global Amlodipine Besylate Revenue Share by Type (2024-2029)
Table 36. Amlodipine Besylate Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Amlodipine Besylate Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Amlodipine Besylate Sales by Application (2018-2024) & (K Units)
Table 39. Global Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 40. Global Amlodipine Besylate Sales Share by Application (2018-2024)
Table 41. Global Amlodipine Besylate Sales Share by Application (2024-2029)
Table 42. Global Amlodipine Besylate Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Amlodipine Besylate Revenue Share by Application (2018-2024)
Table 45. Global Amlodipine Besylate Revenue Share by Application (2024-2029)
Table 46. Amlodipine Besylate Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Amlodipine Besylate Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Amlodipine Besylate Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Amlodipine Besylate Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Amlodipine Besylate Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Amlodipine Besylate Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Amlodipine Besylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Amlodipine Besylate Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Amlodipine Besylate Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Amlodipine Besylate Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 61. Europe Amlodipine Besylate Sales by Type (2018-2024) & (K Units)
Table 62. Europe Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 63. Europe Amlodipine Besylate Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Amlodipine Besylate Sales by Application (2018-2024) & (K Units)
Table 66. Europe Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 67. Europe Amlodipine Besylate Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Amlodipine Besylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Amlodipine Besylate Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Amlodipine Besylate Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Amlodipine Besylate Sales by Country (2018-2024) & (K Units)
Table 73. Europe Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 74. China Amlodipine Besylate Sales by Type (2018-2024) & (K Units)
Table 75. China Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 76. China Amlodipine Besylate Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Amlodipine Besylate Sales by Application (2018-2024) & (K Units)
Table 79. China Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 80. China Amlodipine Besylate Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Amlodipine Besylate Sales by Type (2018-2024) & (K Units)
Table 83. Asia Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 84. Asia Amlodipine Besylate Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Amlodipine Besylate Sales by Application (2018-2024) & (K Units)
Table 87. Asia Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 88. Asia Amlodipine Besylate Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Amlodipine Besylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Amlodipine Besylate Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Amlodipine Besylate Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Amlodipine Besylate Sales by Region (2018-2024) & (K Units)
Table 94. Asia Amlodipine Besylate Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Amlodipine Besylate Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Amlodipine Besylate Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Amlodipine Besylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Amlodipine Besylate Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 108. Pfizer Company Information
Table 109. Pfizer Description and Major Businesses
Table 110. Pfizer Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Pfizer Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Pfizer Recent Developments
Table 113. Mylan Company Information
Table 114. Mylan Description and Major Businesses
Table 115. Mylan Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Mylan Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Mylan Recent Developments
Table 118. Dr. Reddy's Laboratories Company Information
Table 119. Dr. Reddy's Laboratories Description and Major Businesses
Table 120. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Dr. Reddy's Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Dr. Reddy's Laboratories Recent Developments
Table 123. Apotex Company Information
Table 124. Apotex Description and Major Businesses
Table 125. Apotex Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Apotex Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Apotex Recent Developments
Table 128. Teva Pharmaceutical Company Information
Table 129. Teva Pharmaceutical Description and Major Businesses
Table 130. Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Teva Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Teva Pharmaceutical Recent Developments
Table 133. Cipla Company Information
Table 134. Cipla Description and Major Businesses
Table 135. Cipla Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Cipla Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Cipla Recent Developments
Table 138. Hikma Pharmaceuticals Company Information
Table 139. Hikma Pharmaceuticals Description and Major Businesses
Table 140. Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Hikma Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Hikma Pharmaceuticals Recent Developments
Table 143. Strides Pharma Company Information
Table 144. Strides Pharma Description and Major Businesses
Table 145. Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Strides Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Strides Pharma Recent Developments
Table 148. Upsher-Smith Laboratories Company Information
Table 149. Upsher-Smith Laboratories Description and Major Businesses
Table 150. Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Upsher-Smith Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Upsher-Smith Laboratories Recent Developments
Table 153. InvaGen Pharmaceuticals Company Information
Table 154. InvaGen Pharmaceuticals Description and Major Businesses
Table 155. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. InvaGen Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. InvaGen Pharmaceuticals Recent Developments
Table 158. Sun Pharmaceutical Company Information
Table 159. Sun Pharmaceutical Description and Major Businesses
Table 160. Sun Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Sun Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Sun Pharmaceutical Recent Developments
Table 163. Aurobindo Pharma Company Information
Table 164. Aurobindo Pharma Description and Major Businesses
Table 165. Aurobindo Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Aurobindo Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Aurobindo Pharma Recent Developments
Table 168. Lupin Pharmaceuticals Company Information
Table 169. Lupin Pharmaceuticals Description and Major Businesses
Table 170. Lupin Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Lupin Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Lupin Pharmaceuticals Recent Developments
Table 173. Zydus Pharmaceuticals Company Information
Table 174. Zydus Pharmaceuticals Description and Major Businesses
Table 175. Zydus Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Zydus Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Zydus Pharmaceuticals Recent Developments
Table 178. Oxford Pharm Company Information
Table 179. Oxford Pharm Description and Major Businesses
Table 180. Oxford Pharm Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Oxford Pharm Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Oxford Pharm Recent Developments
Table 183. Wockhardt Company Information
Table 184. Wockhardt Description and Major Businesses
Table 185. Wockhardt Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Wockhardt Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Wockhardt Recent Developments
Table 188. Epic Pharma Company Information
Table 189. Epic Pharma Description and Major Businesses
Table 190. Epic Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Epic Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Epic Pharma Recent Developments
Table 193. CR Pharmaceutical Company Information
Table 194. CR Pharmaceutical Description and Major Businesses
Table 195. CR Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. CR Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. CR Pharmaceutical Recent Developments
Table 198. Alkem Laboratories Company Information
Table 199. Alkem Laboratories Description and Major Businesses
Table 200. Alkem Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 201. Alkem Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Alkem Laboratories Recent Developments
Table 203. MACLEODS Company Information
Table 204. MACLEODS Description and Major Businesses
Table 205. MACLEODS Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 206. MACLEODS Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. MACLEODS Recent Developments
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Amlodipine Besylate Distributors List
Table 211. Amlodipine Besylate Customers List
Table 212. Amlodipine Besylate Market Trends
Table 213. Amlodipine Besylate Market Drivers
Table 214. Amlodipine Besylate Market Challenges
Table 215. Amlodipine Besylate Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Amlodipine Besylate Product Picture
Figure 2. Global Amlodipine Besylate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Amlodipine Besylate Market Share by Type in 2022 & 2029
Figure 4. 2.5mg Tablets Product Picture
Figure 5. 5mg Tablets Product Picture
Figure 6. 10mg Tablets Product Picture
Figure 7. Global Amlodipine Besylate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Amlodipine Besylate Market Share by Application in 2022 & 2029
Figure 9. High Blood Pressure
Figure 10. Heart Disease
Figure 11. Amlodipine Besylate Report Years Considered
Figure 12. Global Amlodipine Besylate Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Amlodipine Besylate Revenue 2018-2029 (US$ Million)
Figure 14. Global Amlodipine Besylate Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Amlodipine Besylate Revenue Market Share by Region (2018-2029)
Figure 16. Global Amlodipine Besylate Sales 2018-2029 ((K Units)
Figure 17. Global Amlodipine Besylate Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Amlodipine Besylate Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Amlodipine Besylate Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Amlodipine Besylate Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Amlodipine Besylate Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Amlodipine Besylate Sales YoY (2018-2029) & (K Units)
Figure 23. China Amlodipine Besylate Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Amlodipine Besylate Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Amlodipine Besylate Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Amlodipine Besylate Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Amlodipine Besylate Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Amlodipine Besylate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Amlodipine Besylate in the World: Market Share by Amlodipine Besylate Revenue in 2022
Figure 30. Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Amlodipine Besylate Sales Market Share by Type (2018-2029)
Figure 32. Global Amlodipine Besylate Revenue Market Share by Type (2018-2029)
Figure 33. Global Amlodipine Besylate Sales Market Share by Application (2018-2029)
Figure 34. Global Amlodipine Besylate Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Amlodipine Besylate Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Amlodipine Besylate Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Amlodipine Besylate Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Amlodipine Besylate Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Amlodipine Besylate Revenue Share by Country (2018-2029)
Figure 40. US & Canada Amlodipine Besylate Sales Share by Country (2018-2029)
Figure 41. U.S. Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Amlodipine Besylate Sales Market Share by Type (2018-2029)
Figure 44. Europe Amlodipine Besylate Revenue Market Share by Type (2018-2029)
Figure 45. Europe Amlodipine Besylate Sales Market Share by Application (2018-2029)
Figure 46. Europe Amlodipine Besylate Revenue Market Share by Application (2018-2029)
Figure 47. Europe Amlodipine Besylate Revenue Share by Country (2018-2029)
Figure 48. Europe Amlodipine Besylate Sales Share by Country (2018-2029)
Figure 49. Germany Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 50. France Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 54. China Amlodipine Besylate Sales Market Share by Type (2018-2029)
Figure 55. China Amlodipine Besylate Revenue Market Share by Type (2018-2029)
Figure 56. China Amlodipine Besylate Sales Market Share by Application (2018-2029)
Figure 57. China Amlodipine Besylate Revenue Market Share by Application (2018-2029)
Figure 58. Asia Amlodipine Besylate Sales Market Share by Type (2018-2029)
Figure 59. Asia Amlodipine Besylate Revenue Market Share by Type (2018-2029)
Figure 60. Asia Amlodipine Besylate Sales Market Share by Application (2018-2029)
Figure 61. Asia Amlodipine Besylate Revenue Market Share by Application (2018-2029)
Figure 62. Asia Amlodipine Besylate Revenue Share by Region (2018-2029)
Figure 63. Asia Amlodipine Besylate Sales Share by Region (2018-2029)
Figure 64. Japan Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 68. India Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Amlodipine Besylate Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Amlodipine Besylate Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Amlodipine Besylate Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Amlodipine Besylate Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Amlodipine Besylate Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Amlodipine Besylate Sales Share by Country (2018-2029)
Figure 75. Brazil Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Amlodipine Besylate Revenue (2018-2029) & (US$ Million)
Figure 80. Amlodipine Besylate Value Chain
Figure 81. Amlodipine Besylate Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed